Core Outcome Measures in Effectiveness Trials

ICHOM: Chronic Kidney Disease

General Information

Summary:
The ICHOM Standard Set for Chronic Kidney Disease is the result of hard work by a group of leading physicians, measurement experts and patients. It is our recommendation of the outcomes that matter most to patients with Chronic Kidney Disease. We urge all providers around the world to start measuring these outcomes to better understand how to improve the lives of their patients

Contributors:
Belgium
Andrea Stopper
Wim van Biesen

Germany
Markus Ketteler

Mexico
Guillermo Garcia-Garcia

Netherlands
Hans Bart
Kitty Jager
Marc Hemmelder
Türkan Terkivatan
Willem Jan Bos
Wouter Verberne

Spain
Eduardo ParraMoncasi

Taiwan
Chih-Wei Yang

United Arab Emirates
Muhamed Al Rohani

United Kingdom
Charlotte Roberts
David Wheeler
Elizabeth Gibbons
Zofia Das-Gupta

United States
Andrew Allegretti
Katherine Tuttle
Laurie Konowitz

Further Study Information

Current Stage:
Not applicable
Date:
Not stated
Funding source(s):
ACI NSW Agency for Clinical Innovation, Providence Health & Services, ERCPA, Santeon, Dutch Kidney Foundation

Health Area

Disease Category
Kidney disease

Disease Name
Chronic kidney disease

Target Population

Age Range
-

Sex
Either


Nature / type of Intervention
Hemodialysis
Other
Surgery

Method(s)

Unknown

For Chronic Kidney Disease, the followingtreatment approaches (or interventions) are covered by our Standard Set.Pre-RRT = Pre-Renal Replacement Therapy | HD = Haemodialysis | PD = Peritoneal Dialysis | Tx = Renal Transplantation | CC = Conservative Care


Stakeholders Involved

Clinical experts
Consumers (patients)
Researchers

Study Type

COS for practice

The site uses cookies, some may have been set already. Please refer to our privacy policy & cookie usage statement.
If you continue to use the site we'll assume you're happy to accept the cookies.